What is he best known for?
The fields of study he is best known for:
Chen Liang mainly investigates Virus, Virology, RNA, Genetics and Viral envelope.
The concepts of his Virus study are interwoven with issues in Interferon, Small hairpin RNA and COS cells.
He focuses mostly in the field of Interferon, narrowing it down to matters related to Innate immune system and, in some cases, Effector, Cell and Viral protein.
Chen Liang has included themes like Membrane protein, RNA-binding protein, Mutant and DNA in his Virology study.
His work carried out in the field of Mutant brings together such families of science as Cypa and Cyclophilin A.
He interconnects Molecular biology and Genome in the investigation of issues within RNA.
His most cited work include:
- The IFITM Proteins Inhibit HIV-1 Infection (279 citations)
- The IFITM Proteins Inhibit HIV-1 Infection (279 citations)
- The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection (223 citations)
What are the main themes of his work throughout his whole career to date?
Chen Liang spends much of his time researching Virology, Virus, Viral replication, Molecular biology and RNA.
His Virology study which covers Genetics that intersects with Protein structure.
His Virus study combines topics in areas such as Innate immune system, RNA-binding protein and Effector.
As a part of the same scientific family, Chen Liang mostly works in the field of Viral replication, focusing on Cell biology and, on occasion, HEK 293 cells, Stress granule and SAMHD1.
His Molecular biology research integrates issues from Primer binding site, Reverse transcriptase, Point mutation, Capsid and Group-specific antigen.
His RNA study combines topics from a wide range of disciplines, such as Transcription and Mutant.
He most often published in these fields:
- Virology (91.44%)
- Virus (56.68%)
- Viral replication (46.52%)
What were the highlights of his more recent work (between 2017-2021)?
- Virology (91.44%)
- Cell biology (29.41%)
- Interferon (18.72%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Virology, Cell biology, Interferon, Virus and Viral replication.
His work deals with themes such as Polymerase, Gene and RNA polymerase, which intersect with Virology.
His Cell biology research includes elements of Stress granule, Nuclear export signal and Cytosol.
His Interferon study incorporates themes from Translation, Viral translation, Cell culture and Protein biosynthesis.
His Virus study integrates concerns from other disciplines, such as Innate immune system and Immune system.
His Viral replication research includes themes of RNA and Dengue virus.
Between 2017 and 2021, his most popular works were:
- IFITM proteins inhibit HIV-1 protein synthesis (26 citations)
- Interferons: Reprogramming the Metabolic Network against Viral Infection. (26 citations)
- Interferons: Reprogramming the Metabolic Network against Viral Infection. (26 citations)
In his most recent research, the most cited papers focused on:
Chen Liang mostly deals with Cell biology, Virus, Viral replication, DNA and Signal transduction.
His Cell biology research incorporates themes from Stress granule and APOBEC3G.
His work deals with themes such as Interferon, Drug development, Small molecule, Protein structure and Biological evaluation, which intersect with Virus.
The study incorporates disciplines such as Non-coding RNA and RNA polymerase complex, Polymerase, RNA polymerase, RNA-dependent RNA polymerase in addition to Viral replication.
His study on DNA also encompasses disciplines like
- CRISPR, which have a strong connection to Reverse transcriptase, Primer binding site and Computational biology,
- Cas9 which connect with Subgenomic mRNA, Long terminal repeat, Genome editing and Provirus.
Chen Liang interconnects Nucleic acid, Reprogramming, Innate immune system, Immune system and SAMHD1 in the investigation of issues within Signal transduction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
